SEC Form 4 · accession 0001140361-15-002250
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Gregg Lapointe
Director
Period of report
Jan 15, 2015
Accepted (ET)
Jan 20, 2015 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1 | $9.98 | Jan 15, 2015 | A | 40,000 | A | — | Jan 15, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1Stock options are exercisable at the rate of 1/12th of the original number of shares at each quarterly anniversary of Mr. Lapointe's Vesting Commencement Date (1/1/2015).